Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A

By Gessa G.L.   Mascia M.S.   Casu M.A.   Carta G.  

European Journal of Pharmacology, Vol. 327, Iss. 1, 1997-05 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

SR46349-B, a 5-HT 2A/2C Receptor Antagonist, Potentiates Haloperidol-induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus Accumbens

By Bonaccorso S.   Meltzer H.Y.   Li Z.   Dai J.   Alboszta A.R.   Ichikawa J.  

Neuropsychopharmacology, Vol. 27, Iss. 3, 2002-09 ,pp. : 430-441

Elsevier

Access to resources Recommend Favorite

Effect of amphetamine on extracellular acetylcholine and monoamine levels in subterritories of the rat medial prefrontal cortex

By Hedou G.   Homberg J.   Martin S.   Wirth K.   Feldon J.   Heidbreder C.A.  

European Journal of Pharmacology, Vol. 390, Iss. 1, 2000-02 ,pp. : 127-136

Elsevier

Access to resources Recommend Favorite

Intrategmental infusion of cocaine decreases dopamine release and enhances norepinephrine release in the medial prefrontal cortex

By Pan W.H.T.   Chen N.-H.   Tsai F.-Y.   Liao H.-Y.  

European Journal of Pharmacology, Vol. 317, Iss. 2, 1996-12 ,pp. : 205-213

Elsevier

Access to resources Recommend Favorite

Involvement of -aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex

By Yonezawa Y.   Kuroki T.   Kawahara T.   Tashiro N.   Uchimura H.  

European Journal of Pharmacology, Vol. 341, Iss. 1, 1998-01 ,pp. : 45-56

Elsevier

Access to resources Recommend Favorite